Clinical Trial Update: Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Flovent Discus, QVAR, and Pulmicort Flexhaler for short-term growth effects in asthma patients; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Flovent Discus (fluticasone propionate inhalation)
• PULMICORT FLEXHALER (BUDESONIDE)
• QVAR (beclomethasone dipropionate inhalation aerosol)

Snippet

Sponsor: West Penn Allegheny Health System | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2020-10-12